Jaykay Enterprises Ltd

BSE: 500306

149

total announcements

JAYKAY.NS · 15 min delayed

Key Stats · Yahoo Finance · as of 14 Nov 2026

Market Cap

₹3,164 Cr

P/E (TTM)

14.5

EPS (TTM)

₹14.49

52W Low

₹115.52

52W High

₹273.00

Dividend Yield

0.00%

Beta

0.65

Price / Book

4.3

Debt / Equity

5.6

Revenue (TTM)

₹279 Cr

Gross Margin

92.97%

Operating Margin

11.20%

AnnouncementsDiscussion
BSECompany Update▲ PositiveOrder Win22 Oct 2026

Jaykay Enterprises Ltd

Intimation regarding receipt of License to Manufacture for Sale or for Distribution of Class C or Class D Medical Devices by JK Digital & Advance Systems Private Limited, WOS of Jaykay Enterprises Limited

Jaykay Enterprises Ltd has received a license to manufacture Class C or Class D Medical Devices from the Central Drugs Standard Control Organisation (CDSCO). The license covers eight categories of advanced medical implants, including Lattice Acetabular Cups and Lattice TLIF Spinal Implants. This development strengthens the company's presence in the specialized medical devices segment and provides a regulatory foundation for pursuing opportunities in advanced orthopaedic and spinal implant solutions.

Read more →📎 1 attachment
BSECompany Updateemployee_stock_option21 Oct 2026

Jaykay Enterprises Ltd

Intimation of Grant of Stock Options under JKE Employee Stock Option Scheme 2025

Jaykay Enterprises Ltd has granted 13,000 stock options to eligible employees under the JKE Employee Stock Option Scheme 2025. The options are exercisable within 2 years from vesting, with 33.33% vesting at the end of each year. The exercise price is Rs. 215.01 per stock option, based on the closing market price on October 19, 2026.

Read more →📎 1 attachment
Page 1 of 8Next →